For women with PCOS, GLP-1 receptor agonists have shown better outcomes compared to metformin, particularly in weight loss and improving insulin resistance
Are Lipo C injections FDA-approved for weight loss or fat reduction? No lipotropic injections are compounded preparations that fall under state pharmacy board oversight, not FDA drug approval
Many patients prescribed semaglutide for weight management alongside stimulant medications for ADHD have this important question
Oral GLP-1 receptor agonists are also in the development phase, with preliminary data showing efficacy similar to that of Semaglutide
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine
Given their non-invasive nature, accessibility, and cost-effectiveness of sublingual formulations, they may represent a promising approach for long-term B12 management, particularly in patients with impaired absorption or in resource-limited settings